Nissay Capital
Nissay Capital, established in 1991, is a Tokyo-based venture capital firm. It specializes in providing seed, startup, growth, middle stage, and later stage capital to companies across various sectors, including information technology, manufacturing, medical, distribution, and retail. The firm manages multiple funds, with its most recent being Nissay Capital No. 9. It typically invests a minimum of JPY 1 billion per company, targeting pre-IPO investments with projected market capitalization of JPY 50 billion at IPO.
Past deals in CMS
Medigle
Seed Round in 2025
Medigle is a consulting firm that focuses on medical consulting and B2B services, designed to enhance regional medical cooperation. The company operates a cloud-based system that facilitates the central management of customer information through a referral source medical core. This platform enables hospitals to streamline digital communication, allowing medical professionals to focus on their core areas of expertise. By providing these services, Medigle aims to improve the efficiency and effectiveness of healthcare delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.